1. Home
  2. IRON vs RHI Comparison

IRON vs RHI Comparison

Compare IRON & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$94.29

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$26.95

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
RHI
Founded
2017
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
RHI
Price
$94.29
$26.95
Analyst Decision
Strong Buy
Sell
Analyst Count
12
7
Target Price
$108.83
$40.00
AVG Volume (30 Days)
533.0K
2.5M
Earning Date
11-06-2025
10-22-2025
Dividend Yield
N/A
8.81%
EPS Growth
N/A
N/A
EPS
N/A
1.54
Revenue
N/A
$5,458,499,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.14
P/E Ratio
N/A
$17.39
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$25.22
52 Week High
$97.12
$78.41

Technical Indicators

Market Signals
Indicator
IRON
RHI
Relative Strength Index (RSI) 62.96 43.80
Support Level $87.18 $26.00
Resistance Level $96.18 $28.01
Average True Range (ATR) 3.94 0.90
MACD -0.32 0.20
Stochastic Oscillator 56.25 60.87

Price Performance

Historical Comparison
IRON
RHI

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

Share on Social Networks: